Association between serum uric acid, aortic, carotid and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study

Journal of Hypertension

Volumn 33, Issue 8, 2015, Pages 1642-1650

  Wijnands, José M A ^a,b   Boonen, Annelies ^a,b   Van Sloten, Thomas T ^a,c,d   Schram, Miranda T ^a,c   Sep, Simone J S ^a,c   Koster, Annemarie ^b   Van Der Kallen, Carla J H ^a,c   Henry, Ronald M A ^a,c   Dagnelie, Pieter C ^b,c   Stehouwer, Coen D A ^a,c   Van Der Linden, Sjef ^a,b   Arts, Ilja C W ^b,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

compliance coefficient; distensibility coefficient; pulse wave velocity; uric acid; Young's elastic modulus

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; URICOSURIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; AUTOANALYZER; CARDIOVASCULAR EQUIPMENT; CAROTID FEMORAL PULSE WAVE VELOCITY; CAROTID STIFFNESS; COHORT ANALYSIS; FEMALE; FEMORAL STIFFNESS; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSCILLOMETRY; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; PULSE WAVE; RIGIDITY; SEX; ULTRASOUND SCANNER; URIC ACID BLOOD LEVEL; YOUNG MODULUS; AORTA; BLOOD; CARDIOVASCULAR DISEASE; CAROTID ARTERY; COMPLIANCE (PHYSICAL); CROSS-SECTIONAL STUDY; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; AORTA; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; COMPLIANCE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ELASTIC MODULUS; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; URIC ACID; VASCULAR STIFFNESS;

EID: 84941219556     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000593     Document Type: Article

References (59)

1. Uaratanawong S, Suraamornkul S, Angkeaw S, Uaratanawong R. Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol 2011; 30: 887-893
2. Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res 2006; 37: 883-889
3. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4: 9
4. Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med 2012; 125: 679-687
5. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 2013; 99: 759-766
6. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605
7. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943
8. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269-275
9. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005; 25: 425-433
10. Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanismof uric acid-induced endothelial dysfunction. J Hypertens 2010; 28: 1234-1242
11. Chen X, Li Y, Sheng CS, Huang QF, Zheng Y, Wang JG. Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting. Am J Hypertens 2010; 23: 387-392
12. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 2007; 192: 131-137
13. Khan F, George J, Wong K, McSwiggan S, Struthers AD, Belch JJ. The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors. Atherosclerosis 2008; 200: 374-379
14. Kuo CF, Yu KH, Luo SF, Ko YS, Wen MS, Lin YS, et al. Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a crosssectional study. Rheumatology (Oxford) 2010; 49: 1189-1196
15. Liang J, Li Y, Zhou N, Teng F, Zhao J, Zou C, Qi L. Synergistic effects of serum uric acid and cardiometabolic risk factors on early stage atherosclerosis: the cardiometabolic risk in Chinese study. PLoS One 2012; 7: e51101
16. Park JS, Kang S, Ahn CW, Cha BS, Kim KR, Lee HC. Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women. Maturitas 2012; 73: 344-348
17. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong YY, Kishi R. Relationships of C-reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects. J Hum Hypertens 2005; 19: 907-913
18. Shin JY, Lee HR, Shim JY. Significance of high-normal serum uric acid level as a risk factor for arterial stiffness in healthy Korean men. Vasc Med 2012; 17: 37-43
19. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement: a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309
20. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH. Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels 2009; 24: 371-375
21. Vlachopoulos C, Xaplanteris P, Vyssoulis G, Bratsas A, Baou K, Tzamou V, et al. Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension. Am J Hypertens 2011; 24: 33-39
22. Maldonado J, Pereira T, Polonia J, Silva JA, Morais J, Marques M. Arterial stiffness predicts cardiovascular outcome in a low-to-moderate cardiovascular risk population: the EDIVA (Estudo De DIstensibilidade VAscular) project. J Hypertens 2011; 29: 669-675
23. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664-670
24. Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Gomez-Sanchez L, et al. Relationship between uric acid and vascular structure and function in hypertensive patients and sex-related differences. Am J Hypertens 2013; 26: 599-607
25. Hsu PF, Chuang SY, Cheng HM, Sung SH, Ting CT, Lakatta EG, et al. Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure. Int J Cardiol 2013; 168: 2057-2063
26. Lim JH, Kim YK, Kim YS, Na SH, Rhee MY, Lee MM. Relationship between serum uric acid levels, metabolic syndrome, and arterial stiffness in Korean. Korean Circ J 2010; 40: 314-320
27. Tsioufis C, Kyvelou S, Dimitriadis K, Syrseloudis D, Sideris S, Skiadas I, et al. The diverse associations of uric acid with low-grade inflammation, adiponectin and arterial stiffness in never-treated hypertensives. J Hum Hypertens 2011; 25: 554-559
28. Cicero AF, Salvi P, D'Addato S, Rosticci M, Borghi C. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens 2014; 32: 57-64
29. Cipolli JA, Ferreira-Sae MC, Martins RP, Pio-Magalhaes JA, Bellinazzi VR, Matos-Souza JR, Junior WN. Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a crosssectional study. BMC Cardiovasc Disord 2012; 12: 52
30. Oikonen M, Wendelin-Saarenhovi M, Lyytikainen LP, Siitonen N, Loo BM, Jula A, et al. Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study. Atherosclerosis 2012; 223: 497-503
31. Dijk JM, van der Graaf Y, Grobbee DE, Bots ML. Carotid stiffness indicates risk of ischemic stroke and TIA in patients with internal carotid artery stenosis: the SMART study. Stroke 2004; 35: 2258-2262
32. Lovett JK, Howard SC, Rothwell PM. Pulse pressure is independently associated with carotid plaque ulceration. J Hypertens 2003; 21: 1669-1676
33. van De Laar RJ, Ferreira I, van Mechelen W, Prins MH, Twisk JW, Stehouwer CD. Habitual physical activity and peripheral arterial compliance in young adults: the Amsterdamgrowth and health longitudinal study. Am J Hypertens 2011; 24: 200-208
34. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. J Am Med Assoc 2000; 283: 2404-2410
35. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13
36. Kramer CK, von Muhlen D, Jassal SK, Barrett-Connor E. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study. J Intern Med 2010; 267: 561-566
37. Padova J, Patchefsky A, Onesti G, Faludi G, Bendersky G. The effect of glucose loads on renal uric acid excretion in diabetic patients. Metabolism 1964; 13: 507-512
38. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268: E1-5
39. Schram MT, Sep SJS, Kallen van der CJ, Dagnelie PC, Koster A, Schaper N, et al. The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epid 2014; 29: 439-451
40. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101-1109
41. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30: 445-448
42. Hermeling E, Reesink KD, Kornmann LM, Reneman RS, Hoeks AP. The dicrotic notch as alternative time-reference point to measure local pulse wave velocity in the carotid artery by means of ultrasonography. J Hypertens 2009; 27: 2028-2035
43. Willekes C, Hoeks AP, Bots ML, Brands PJ, Willigers JM, Reneman RS. Evaluation of off-line automated intima-media thickness detection of the common carotid artery based on M-line signal processing. Ultrasound Med Biol 1999; 25: 57-64
44. Reneman RS, Meinders JM, Hoeks AP. Noninvasive ultrasound in arterial wall dynamics in humans: what have we learned and what remains to be solved. Eur Heart J 2005; 26: 960-966
45. Kelly R, Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. J Am Coll Cardiol 1992; 20: 952-963
46. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, et al. Noninvasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 2001; 19: 1037-1044
47. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
48. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva, Switzerland: World Health Organization (WHO); 2006
49. Takahashi S, Moriwaki Y, Yamamoto T, Tsutsumi Z, Ka T, Fukuchi M. Effects of combination treatment using antihyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism. Ann Rheum Dis 2003; 62: 572-575
50. Hamada T, Ichida K, Hosoyamada M, Mizuta E, Yanagihara K, Sonoyama K, et al. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. Am J Hypertens 2008; 21: 1157-1162
51. Chanard J, Toupance O, Lavaud S, Hurault De Ligny B, Bernaud C, Moulin B. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients. Nephrol Dial Transplant 2003; 18: 2147-2153
52. Ogata N, Fujimori S, Oka Y, Kaneko K. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. Nucleos Nucleot Nucl 2010; 29: 321-324
53. Uetake D, Ohno I, Ichida K, Yamaguchi Y, Saikawa H, Endou H, Hosoya T. Effect of fenofibrate on uric acid metabolism and urate transporter 1. Intern Med 2010; 49: 89-94
54. Greenwald SE. Ageing of the conduit arteries. J Pathol 2007; 211: 157-172
55. Roach MR, Burton AC. The reason for the shape of the distensibility curves of arteries. Can J Biochem Physiol 1957; 35: 681-690
56. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 2004; 43: 163-168
57. Sedaghat S, Hoorn EJ, van Rooij FJ, Hofman A, Franco OH, Witteman JC, Dehghan A. Serum uric Acid and chronic kidney disease: the role of hypertension. PLoS One 2013; 8: e76827
58. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb 1993; 13: 90-97
59. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004; 43: 1239-1245